Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

Todd Neale

February 19, 2025

News Conference News THT 2025

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Todd Neale

February 18, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

News Conference News THT 2023

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

Todd Neale

March 23, 2023

News Conference News THT 2023

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

Shelley Wood

March 22, 2023

News Conference News THT 2023

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Todd Neale

March 21, 2023

$Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?$

Presentation THT 2023

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

Presenter: Michael Sutherland

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

Advertisement

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

HF Benefits Look Durable in Single-Arm Study of Coronary Sinus Shunt

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Debating the Role of T-TEER in the Sickest Patients

The Promise of AI for Improving Health Equity in Heart Failure

High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF

Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF

Promising Preliminary Results for AccuCinch LV Restoration System in HFrEF

Hierarchical composite endpoints for heart failure trials - answering the question: What fraction of the composite endpoint is due to cardiovascular mortality, hospitalization, or quality of life?

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content